Stock

Clusters of Long Winning Streaks: What They’re Telling Us

June 6, 2025
Stock

Three Charts Showing Proper Moving Average Alignment

June 6, 2025
Investing

Offer Booklet – Non-Renounceable Entitlement Offer

June 6, 2025
Investing

In-fill RC Drilling at Kamperman Confirms High-Grade Gold

June 6, 2025
Investing

Trump Admin Strips “Safety” from AI Oversight Institute in Move to Rebrand

June 6, 2025
Investing

Should You Invest in Silver Bullion?

June 6, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Collaboration with DuPont Water Solutions to Test Lithium...

April 17, 2025

Web3 Leaders Gather in Toronto for Canada Crypto...

May 13, 2025

$2.6M Placement and SPP to fast-track China entry...

May 9, 2025

Thick High-Grade Graphite Drilling Results In New Zone

May 23, 2025

John Rubino: Gold on “Epic Run” as Chaos...

May 3, 2025

JZR Gold Inc. Announces Completion of Testing of...

May 14, 2025

Feedback of U.S. Department of Defense Award Funding

May 19, 2025

NorthStar Gaming to Host Q4 and Year-End 2024...

April 17, 2025

Providence Update on Tuolumne Property Lease

April 22, 2025

Tech 5: Major Players Release Latest Results, Google’s...

April 27, 2025